Home > Insider Trading > Filing (0001140361-12-045904)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1176309	Oramed Pharmaceuticals Inc.	ORMP	Pharmaceutical Preparations (2834)	980376008

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1477733	Mark David Slager	152 West 57Th Street, 9Th Floor New York NY 10019	No	No	Yes	No
1542836	Regals Fund Lp	152 West 57Th Street, 9Th Floor New York NY 10019	No	No	Yes	No
1542838	Regals Capital Management Lp	152 West 57Th Street 9Th Floor New York NY 10019	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-11-02	405,405	$0.00	9,127,670	No	4	P	Indirect	See

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrants (Right to Purchase)	Acquisiton	2012-11-02	202,703	$0.00	202,703	$0.50

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
202,703	2012-11-02	2017-11-02	No	4	P	Indirect

Footnotes

On November 2, 2012, the Fund purchased units representing 405,405 shares of common stock and the 202,703 warrants described in this Form 4 for $0.37 per unit.
Regals Capital Management LP, a Delaware limited partnership ("Regals Management"), Regals Fund LP, a Delaware limited partnership (the "Fund"), and David M. Slager ("Mr. Slager"), are the reporting persons (the "Reporting Persons") for the referenced securities. Mr. Slager is Managing Member of the general partner of Regals Management. Regals Management is the investment manager of the Fund. The shares of the issuer's common stock reported herein are held for the account of the Fund.
As a result, each of the Reporting Persons may be deemed to be a beneficial owner of the securities owned by the Fund for purposes of Rule 16a-1(a)(1) under the Securities Exchange Act of 1934, as amended (the "Act"). Pursuant to Rule 16a-1(a)(4) under the Act, Regals Management and Mr. Slager disclaim beneficial ownership in the securities owned by the Fund except to the extent, if any, of their pecuniary interest therein.